Actively Recruiting
Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.
Led by China-Japan Friendship Hospital · Updated on 2026-01-13
50
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to obtain short-term clinical results on the safety and efficacy of single-port robot-assisted metabolic weight loss surgery, and to provide further evidence for the clinical promotion of single-port robot systems.
CONDITIONS
Official Title
Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Overweight or obese patients who meet the criteria for metabolic weight loss surgery, with a BMI 27 27.5 kg/m2
- Patients who understand the purpose of the trial, voluntarily participate in the trial, and sign an informed consent form.
You will not qualify if you...
- Patients who cannot tolerate general anesthesia, such as those with severe heart, lung, or liver dysfunction
- Patients with severe coagulation disorders
- Pregnant patients
- Patients with concurrent tumors
- Patients with extensive and severe abdominal adhesions that prevent the establishment of pneumoperitoneum
- A BMI > 50 kg/m2 is a relative contraindication
- Patients deemed unsuitable for participation in this trial by any other investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China-Japan Friendship Hospital
Beijing, China
Actively Recruiting
Research Team
S
SIQi Wang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here